Estimation of antimicrobial resistance of Mycoplasma genitalium, Belgium, 2022.

BackgroundAntimicrobial resistance (AMR) of Mycoplasma genitalium (MG) is a growing concern worldwide and surveillance is needed. In Belgium, samples are sent to the National Reference Centre of Sexually Transmitted Infections (NRC-STI) on a voluntary basis and representative or robust national AMR data are lacking.AimWe aimed to estimate the occurrence of resistant MG in Belgium.MethodsBetween July and November 2022, frozen remnants of MG-positive samples from 21 Belgian laboratories were analysed at the NRC-STI. Macrolide and fluoroquinolone resistance-associated mutations (RAMs) were assessed using Sanger sequencing of the 23SrRNA and parC gene. Differences in resistance patterns were correlated with surveillance methodology, socio-demographic and behavioural variables via Fisher's exact test and logistic regression analysis.ResultsOf the 244 MG-positive samples received, 232 could be sequenced for macrolide and fluoroquinolone RAMs. Over half of the sequenced samples (55.2%) were resistant to macrolides. All sequenced samples from men who have sex with men (MSM) (24/24) were macrolide-resistant. Fluoroquinolone RAMs were found in 25.9% of the samples and occurrence did not differ between socio-demographic and sexual behaviour characteristics.ConclusionAlthough limited in sample size, our data suggest no additional benefit of testing MG retrieved from MSM for macrolide resistance in Belgium, when making treatment decisions. The lower occurrence of macrolide resistance in other population groups, combined with emergence of fluoroquinolone RAMs support macrolide-resistance testing in these groups. Continued surveillance of resistance in MG in different population groups will be crucial to confirm our findings and to guide national testing and treatment strategies.

Comparison of resin-containing BACTEC Plus Aerobic/F* medium with conventional methods for culture of normally sterile body fluids.

The sensitivity of culture in Bactec Plus Aerobic/F* culture vials of body fluids from adult patients at a university hospital was compared with that of conventional culture methods, including enrichment in Schaedler broth. Previous antibiotic therapy was recorded at the time of sampling. Analysis of culture results took account of the clinical significance of isolates and impact on therapy. Of 336 specimens evaluated, 81 (24%) yielded positive cultures, of which 50 cultures (15%) were considered to be clinically significant (yielding 71 isolates) and 31 (9%) were considered contaminated. Of the 71 pathogens, 16 (23%) were isolated in the Bactec system only, whereas 13 (18%) grew in conventional media only; 12 of the latter were strict anaerobes. Among clinically significant positive specimens, 19 (38%) were from patients receiving antibiotic therapy. In 27 cases (8% of all specimens and 54% of significantly positive cultures), the isolation of a pathogen led to modification of therapy. Overall, culture in the Bactec system showed higher sensitivity for the isolation of aerobic micro-organisms than Schaedler broth. Most of the difference was due to a better recovery of Streptococcaceae. Additional pathogens found only in resin-containing Bactec media led to 30% of all culture-influenced modifications of empirical therapy. These data confirm that culture of normally sterile body fluids frequently yields results that are useful for guiding therapy. Although more costly than standard enrichment broth, the resin-containing Bactec Plus Aerobic/F* vial can be advantageous for culture of aerobic pathogens from these specimens, particularly in patients receiving antibiotic therapy.